Biogen (BIIB)

Other Income/Expenses (Net)

-$185.70M

Quarterly · Period ending: · USD

BIIB logo

BIIB Other Income/Expenses (Net)

Latest reported-$185.70M
BIIB Quarterly Other Income/Expenses (Net) (-$4.00M → -$185.70M)
High-resolution chart · PNG

BIIB other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
11,533,000
16,463,000
9,784,000
33,204,000
16,737,000
99,024,000
7,865,000
8,200,000
-9,229,000
6,280,000
-1,446,000
7,100,000
6,200,000
6,800,000
-15,700,000
5,600,000
5,200,000
4,700,000
-12,900,000
4,200,000
4,200,000
4,500,000
-12,500,000
4,600,000
4,400,000
3,900,000
400,000
0
3,900,000
3,500,000
10,900,000
3,500,000
-3,000,000
3,000,000
2,900,000
2,800,000
3,400,000
2,800,000
2,500,000
2,200,000
2,100,000
1,900,000
1,300,000
2,200,000
2,500,000
1,600,000
3,300,000
2,800,000
-6,900,000
-8,100,000
26,900,000
-3,600,000
-5,800,000
-5,600,000
31,000,000
-1,800,000
-1,700,000
-3,200,000
34,700,000
-700,000
-2,000,000
-2,800,000
45,100,000
-4,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.